Figure 1. Example of timing and ordering of presentation of pictures and drinks during the run. Drops represent delivery of a chocolate milkshake (brown) or a tasteless solution (blue).
Figure 2. Activation in a region of the anterior cingulate cortex (Montreal Neurological Institute coordinates x, y, z:−9, 24, 27; z = 4.64; false discovery rate–corrected P < .001) during milkshake cues vs tasteless solution cues as a function of Yale Food Addiction Scale scores, with the graph of parameter estimates (PE) from that peak.
Figure 3. Activation in a region of the medial orbitofrontal cortex (Montreal Neurological Institute coordinates x, y, z: 3, 42,−15; z = 3.47; false discovery rate–corrected P = .004) during milkshake cues vs tasteless solution cues as a function of Yale Food Addiction Scale scores, with the graph of parameter estimates (PE) from that peak.
Figure 4. Activation in a region of the dorsolateral prefrontal cortex (DLPFC) (Montreal Neurological Institute coordinates x, y, z:−27, 27, 36; z = 3.72; false discovery rate–corrected P = .007) during anticipatory food reward (milkshake cue vs tasteless solution cue) in the high food addiction (FA) group vs the low FA group, with the bar graphs of parameter estimates (PE) from that peak.
Figure 5. Activation in a region of the caudate (Montreal Neurological Institute coordinates x, y, z: 9,−3, 21; z = 3.96; false discovery rate–corrected P = .004) during anticipatory food reward (milkshake cue vs tasteless solution cue) in the high food addiction (FA) group vs the low FA group, with the bar graphs of parameter estimates (PE) from that peak.
Figure 6. Activation in a region of the lateral orbitofrontal cortex (Montreal Neurological Institute coordinates x, y, z:−42, 42,−12; z = −3.45; false discovery rate–corrected P = .009) during consummatory reward (milkshake receipt vs tasteless solution receipt) in the high food addiction (FA) group vs the low FA group, with the bar graphs of parameter estimates (PE) from that peak.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Gearhardt AN, Yokum S, Orr PT, Stice E, Corbin WR, Brownell KD. Neural Correlates of Food Addiction. Arch Gen Psychiatry. 2011;68(8):808–816. doi:10.1001/archgenpsychiatry.2011.32
Context Research has implicated an addictive process in the development and maintenance of obesity. Although parallels in neural functioning between obesity and substance dependence have been found, to our knowledge, no studies have examined the neural correlates of addictive-like eating behavior.
Objective To test the hypothesis that elevated“food addiction” scores are associated with similar patterns of neural activation as substance dependence.
Design Between-subjects functional magnetic resonance imaging study.
Setting A university neuroimaging center.
Participants Forty-eight healthy young women ranging from lean to obese recruited for a healthy weight maintenance trial.
Main Outcome Measure The relation between elevated food addiction scores and blood oxygen level–dependent functional magnetic resonance imaging activation in response to receipt and anticipated receipt of palatable food (chocolate milkshake).
Results Food addiction scores (N = 39) correlated with greater activation in the anterior cingulate cortex, medial orbitofrontal cortex, and amygdala in response to anticipated receipt of food (P < .05, false discovery rate corrected for multiple comparisons in small volumes). Participants with higher (n = 15) vs lower (n = 11) food addiction scores showed greater activation in the dorsolateral prefrontal cortex and the caudate in response to anticipated receipt of food but less activation in the lateral orbitofrontal cortex in response to receipt of food (false discovery rate–corrected P < .05).
Conclusions Similar patterns of neural activation are implicated in addictive-like eating behavior and substance dependence: elevated activation in reward circuitry in response to food cues and reduced activation of inhibitory regions in response to food intake.
One-third of American adults are now obese1 and obesity-related disease is the second leading cause of preventable death.2 Unfortunately, most obesity treatments do not result in lasting weight loss because most patients regain their lost weight within 5 years.3
Based on numerous parallels in neural functioning associated with substance dependence (in the current article, the terms substance dependence and addiction are used interchangeably to represent a diagnosis of substance dependence as defined by the DSM-IV-TR4) and obesity, theorists have proposed that addictive processes may be involved in the etiology of obesity.5,6 Food and drug use both result in dopamine release in mesolimbic regions and the degree of release correlates with subjective reward from both food and drug use.6,7 Similar patterns of brain activation in response to food and drug cues have also been found. Individuals with vs without substance dependence show greater activation in brain regions that encode the reward value of stimuli (eg, the orbitofrontal cortex [OFC], amygdala, insula, striatum, anterior cingulate cortex [ACC], and dorsolateral prefrontal cortex [DLPFC])8,9 and greater dopamine release in the dorsal striatum in response to drug cues.10 Similarly, obese vs lean individuals show greater activation in the OFC, amygdala, ACC, striatum, and mediodorsal thalamus in response to food cues8 and greater activation in regions associated with cue-related craving for drugs, such as the ACC, striatum, insula, and the DLPFC, in response to anticipated receipt of palatable foods.11-13
Although obese and substance-dependent individuals show hyperresponsivity of reward learning regions to food and substance cues, respectively, actual intake of food and drugs is associated with reduced reward circuitry activation. Obese vs lean individuals show less dorsal striatal and medial OFC activation in response to palatable food intake,14,15 echoing evidence that substance-dependent individuals exhibit blunted dopaminergic release during actual drug consumption and report weaker subjective reward relative to healthy controls.16-19 Results dovetail with evidence of reduced D2 receptor availability in obese and substance-dependent individuals vs healthy controls.20,21 These findings have prompted the theory that individuals who experience less reward from food intake may overeat to compensate for this reward deficit.20,22
Although there are strong parallels in brain regions that encode reward from drugs and palatable foods and in neural abnormalities associated with substance dependence and obesity, these findings may tell us little about true“food addiction” (FA). Obesity is strongly linked to excess food consumption, but other factors contribute to unhealthy weight gain, such as physical inactivity.23 Additionally, excess consumption is not necessarily indicative of substance dependence; whereas 40% of college students binge drink,24 only 6% meet criteria for alcohol dependence.25 Thus, to more directly assess FA, it would be useful to identify participants who may exhibit signs of dependence in their eating behavior. Currently, a diagnosis of substance dependence is given when sufficient behavioral criteria are met (Table 1). The Yale Food Addiction Scale (YFAS) was developed to operationalize the construct of palatable food dependence based on the DSM-IV-TR4 substance dependence criteria.26 The identification of individuals who exhibit FA symptoms would allow for more direct examinations of the neurobiological similarities between substance dependence and compulsive food consumption.
In the present study, we examined the relation of FA symptoms, as assessed by the YFAS, with neural activation in response to (1) cues signaling impending delivery of a highly palatable food (chocolate milkshake) vs a tasteless control solution and (2) intake of a chocolate milkshake vs a tasteless solution among healthy young women ranging from lean to obese. Based on previous findings, we hypothesized that participants exhibiting elevated FA symptoms would show greater activation in response to food cues in the amygdala, striatum, OFC, DLPFC, thalamus, midbrain, insula, and anterior cingulate gyrus. Further, we hypothesized that, during consumption of a highly palatable food, the high vs low FA group would demonstrate less activation in the dorsal striatum and OFC, analogous to the reduced activation demonstrated in substance-dependent participants on receipt of a drug.
Participants were 48 young women (mean [SD] age = 20.8 [1.31] years; mean [SD] body mass index [calculated as weight in kilograms divided by height in meters squared] [BMI] = 28.0 [3.0]; range, 23.8-39.2) who enrolled in a program developed to help people achieve and maintain a healthy weight on a long-term basis. Data from this sample have been published previously.15,27 Individuals who reported DSM-IV binge eating or compensatory behaviors (eg, vomiting for weight control), use of psychotropic medications or illicit drugs over the past 3 months, smoking, head injury with a loss of consciousness, or current (past 3 months) Axis I psychiatric disorder were excluded. Written informed consent was obtained from participants. The local institutional review board approved this study.
The BMI was used to reflect adiposity. After removal of shoes and coats, height was measured to the nearest millimeter using a stadiometer and weight was assessed to the nearest 0.1 kg using a digital scale. Two measures of height and weight were obtained and averaged.
The YFAS26 is a 25-item measure developed to operationalize FA by assessing signs of substance-dependence symptoms (eg, tolerance, withdrawal, loss of control) in eating behavior. The YFAS has shown internal consistency (α = .86), as well as convergent and incremental validity. The YFAS provides 2 scoring options: a symptom count version and a diagnostic version. To receive a“diagnosis” of FA, it is necessary to report experiencing 3 or more symptoms in the past year and clinically significant impairment or distress. The version of the YFAS used in the current study measured all items on a Likert scale. In line with YFAS scoring instructions, 5 of the Likert scale items were dichotomized, such that participants who indicated that they had never experienced the symptom were assigned a value of zero, and those reporting ever experiencing the symptom in the past year were assigned a value of 1.
The YFAS scores exhibited a normal distribution (skew and kurtosis coefficients<2). Four participants with significant missing data on the YFAS and 5 participants who showed excessive head movement during the scan were excluded, resulting in a final sample size of 39. The primary aim was to test whether YFAS scores correlate with neural activation in brain regions associated with substance dependence. We expected YFAS scores to correlate positively with activation in regions that encode the reward value of stimuli in response to anticipated receipt of palatable food but negatively with activation in these regions in response to food intake. Secondary analyses explored potential differences in activation of participants who likely experienced FA compared with healthy controls. Few participants reported experiencing clinically significant impairment or distress on the YFAS (n = 2), potentially because of the exclusion of participants with eating disorders and Axis I disorders. To more closely approximate those exhibiting signs of food-related substance dependence vs healthy eating behaviors, participants were placed into a high FA group with 3 or more symptoms (n = 15) and a low FA group with 1 or fewer symptoms (n = 11). Participants reporting 2 symptoms were omitted from these analyses (n = 13) to ensure adequate separation between high and low FA groups.
Participants were scanned at baseline. Participants were asked to consume regular meals but to refrain from eating or drinking (including caffeinated beverages) for 4 to 6 hours immediately preceding their imaging session. This deprivation period was selected to capture the hunger state that most individuals experience as they approach their next meal, which is a time when individual differences in food reward would logically impact caloric intake. Most participants completed the paradigm between 10 AM and 1 PM, but a subset completed scans between 2 and 4 PM. Before the imaging session, participants were familiarized with the functional magnetic resonance imaging (MRI) paradigm through practice on a separate computer.
The milkshake paradigm was designed to examine activation in response to consumption and anticipated consumption of palatable food (Figure 1). Stimuli consisted of 2 images (glass of milkshake and glass of water) that signaled the delivery of either 0.5 mL of a chocolate milkshake (4 scoops of Häagen-Dazs vanilla ice cream [Häagen-Dazs, Oakland, California], 1.5 cups of 2% milk, and 2 tablespoons of Hershey's chocolate syrup [The Hershey Company, Hershey, Pennsylvania]) or a calorie-free tasteless solution designed to mimic the natural taste of saliva (25mM potassium chloride and 2.5mM sodium bicarbonate diluted in 500 mL of distilled water). We used artificial saliva because water has a taste that activates the taste cortex.28 Order of presentation was randomized across participants. Images were presented for 2 seconds using MATLAB29 followed by a jitter of 1 to 3 seconds during which a blank screen with a cross-hair at the center for fixation was presented (to eliminate random eye movement). Taste delivery occurred 5 seconds after onset of the cue and lasted 5 seconds. On 40% of the chocolate and tasteless solution trials, the taste was not delivered as expected to allow the investigation of the neural response to anticipation of a taste that was not confounded with actual food receipt (unpaired trials). Each run consisted of 30 events each of milkshake cue and milkshake intake and 20 events each of tasteless solution cue and of tasteless solution intake. Fluids were delivered using programmable syringe pumps (BS-8000; Braintree Scientific, Braintree, Massachusetts) controlled by MATLAB to ensure consistent volume, rate, and timing of taste delivery. Sixty-milliliter syringes filled with chocolate milkshake and tasteless solution were connected via tubing (Tygon; Saint-Gobain, Courbevoie, France) through a wave guide to a manifold attached to the scanner head coil. The manifold fit into the participants' mouths and delivered the taste to a consistent segment of the tongue. Participants were instructed to swallow when they saw the“swallow” cue. Images were presented with a digital projector/reverse-screen display system at the end of the MRI scanner bore, visible via a head coil–mounted mirror. Before the scan, participants consumed the milkshake and tasteless solution and rated desire for perceived pleasantness, edibility, and intensity of the tastes on cross-modal visual analog scales. This procedure has been successfully used in the past to deliver liquids in the scanner, as described in detail elsewhere.15
Scanning was performed with a 3-T head-only MRI scanner. A standard birdcage coil acquired data from the entire brain. A thermo foam vacuum pillow and padding restricted head motion. In total, 229 volumes were collected during each functional run. Functional scans used a T2*-weighted gradient single-shot echo planar imaging sequence (echo time = 30 milliseconds, repetition time = 2000 milliseconds, flip angle = 80°) with an in-plane resolution of 3.0 3.0 mm2 (64 64 matrix; 192 192 mm2 field of view). To cover the whole brain, thirty-two 4-mm slices (interleaved acquisition, no skip) were acquired along the anterior commissure–posterior commissure transverse oblique plane as determined by the midsagittal section. Structural scans were collected using an inversion recovery T1-weighted sequence (magnetization-prepared rapid-acquisition gradient echo) in the same orientation as the functional sequences to provide detailed anatomic images aligned to the functional scans. High-resolution structural MRI sequences (field of view = 256 256 mm2, 256 256 matrix, thickness = 1.0 mm, slice number = about 160) were acquired.
Data were preprocessed and analyzed using SPM5 software30 in MATLAB.29,31 Images were time-acquisition corrected to the slice obtained at 50% of the repetition time. Functional images were realigned to the mean. Anatomic and functional images were normalized to the standard Montreal Neurological Institute template brain implemented in SPM5 (ICBM152, based on an average of 152 normal MRI scans). Normalization resulted in a voxel size of 3 mm3 for functional images and 1 mm3 for structural images. Functional images were smoothed with a 6-mm full-width-at-half-maximum isotropic gaussian kernel. Excessive movement was probed using the realignment parameters and was defined as movement more than 1 mm in any direction during the paradigm. To identify brain regions activated by anticipation of food receipt, we contrasted blood oxygen level–dependent response during an unpaired milkshake cue vs an unpaired tasteless solution cue. We analyzed data from the unpaired cue presentation in which the tastes were not delivered to ensure that taste receipt would not influence our definition of anticipatory activation. We contrasted blood oxygen level–dependent response during receipt of the milkshake vs the tasteless solution to identify brain regions activated in response to food consumption. We considered the arrival of a taste in the mouth to be consummatory reward, rather than when the solution was swallowed, but acknowledge that postingestive effects contribute to the reward value of food.32 Condition-specific effects at each voxel were estimated using general linear models. Vectors of the onsets for each event of interest were compiled and entered into the design matrix so that event-related responses could be modeled by the canonical hemodynamic response function, as implemented in SPM5, consisting of a mixture of 2γ functions that emulate the early peak at 5 seconds and the subsequent undershoot. To account for the variance induced by swallowing the solutions, we included the time of the swallow cue as a control variable. We also included temporal derivatives of the hemodynamic function to obtain a better model of the data.33 A 128-second high-pass filter (per SPM5 convention) removed low-frequency noise and slow drifts in the signal.
Individual maps were constructed to compare the activations within each participant for the contrasts“unpaired milkshake cue vs unpaired tasteless solution cue” and“milkshake receipt vs tasteless solution receipt,” which were then regressed against total YFAS scores using SPM5. To detect group differences, 2 second-level 2 2 analyses of variance were conducted: (high FA group vs low FA group) (milkshake receipt vs tasteless solution receipt) and (high FA group vs low FA group) (unpaired milkshake cue vs unpaired tasteless solution cue). The T-map threshold was set at P uncorrected = .001 and a 3-voxel cluster size. We performed small volume correction analyses using peaks with the highest volumes (millimeters cubed) and z values identified previously in the cue-induced craving and drug administration literature9,34,35 as well as in food cue/food administration studies.15,36,37 To test our hypothesis that participants exhibiting more FA symptoms would demonstrate greater activation in response to food cues, search volumes were restricted within a 10-mm radius of reference coordinates in the OFC (42, 46,−16;−8, 60,−14), caudate (9, 0, 21), amygdala (−12,−10,−16), ACC (−10, 24, 30;−4, 30, 16), DLPFC (−30, 36, 42), thalamus (−7,−26, 9), midbrain (−12,−20,−22; 3,−28,−13), and insula (36, 12, 2). To test our hypothesis that during consumption of a highly palatable food, the high vs low FA group would demonstrate less activation in reward-related brain regions, search volumes were restricted within a 10-mm radius of reference coordinates in the OFC (±42, 46,−16;±41, 34,−19;±8, 60,−14) and caudate (±9, 0, 21;±2,−9, 34). Predicted activations were considered to be significant at P < .05 after correcting for multiple comparisons (false discovery rate corrected) across the voxels within the a priori–defined small volumes. Bonferroni corrections were then used to correct for the number of regions of interest tested. Because Dreher et al38 reported that women in the midfollicular phase (4-8 days after first period) show greater response in reward regions compared with those in the luteal phase, we attempted to run the scans for all women during the same period of the menstrual cycle. However, because of scheduling difficulties, 2 participants were scanned during the midfollicular phase. When these individuals were excluded, the relations between YFAS score and blood oxygen level–dependent responses to food intake and anticipated intake remained significant.
On average, participants with high FA endorsed approximately 4 FA symptoms (mean [SD] = 3.60 [0.63]), whereas the low FA group all endorsed 1 FA symptom. There were no significant differences found between the high and low FA groups on age (F1,24 = 2.25; P = .15), BMI (F1,24 = 1.14; P = .30), or pleasantness ratings of the milkshake administered during the study (F1,24 = 0.013; P = .91). The YFAS scores in the current study correlated with the emotional eating (rs = 0.34; P = .03) and external eating (rs = 0.37; P = .02) subscales of the Dutch Eating Behavior Questionnaire.39
The YFAS scores (N = 39) showed positive correlations with activation in the left ACC (Figure 2), left medial OFC (Figure 3), and left amygdala in response to anticipated intake of palatable food (Table 2). (All peaks remained significant when BMI was statistically controlled for in analyses.) The activation in the left ACC and left OFC survived the more stringent Bonferroni correction (0.05/11 regions of interest = 0.0045). We derived the effect sizes (r) from the z values (z /√N). Effect sizes were all medium to large per the Cohen criteria40 (mean r = .60). There were no significant correlations in the hypothesized regions in response to consumption of palatable food.
Participants in the high FA group vs the low FA group showed greater activation in the left DLPFC (Figure 4) and right caudate (Figure 5) in response to anticipated intake of palatable food. The activation in the right caudate survived the Bonferroni correction (0.05/11 regions of interest = 0.0045). Further, the high FA group showed less activation in the left lateral OFC (Figure 6) during food intake than the low FA group (Table 3). This peak also survived the Bonferroni correction (0.05/3 regions of interest = 0.017). Effect sizes from these analyses were large (mean r = 0.71).
In the current study, lean and obese participants with higher FA scores demonstrated a differential pattern of neuronal activation from participants with lower FA scores. Although studies have explored the association of anticipatory and consummatory reward with BMI,13-15 to our knowledge, this is the first study to examine the relation between FA and neural activation of reward circuitry with intake and anticipated intake of palatable food. The FA scores correlated positively with activation in the ACC, medial OFC, and amygdala in response to anticipated intake of palatable food but were not significantly related to activation in response to palatable food intake. Further, participants with high vs low FA demonstrated greater activation in the DLPFC and caudate during anticipated palatable food intake and reduced activation in the lateral OFC during palatable food intake.
As predicted, elevated FA scores were associated with greater activation of regions that play a role in encoding the motivational value of stimuli in response to food cues. The ACC and medial OFC have both been implicated in motivation to feed41,42 and to consume drugs among individuals with substance dependence.43 Elevated ACC activation in response to alcohol-related cues is also associated with reduced D2 receptor availability44 and increased risk for relapse.45 Similarly, increased activation in the amygdala is associated with increased appetitive motivation46 and exposure to foods with greater motivational and incentive value.47 In addition, the DLPFC is associated with memory, planning,48 attentional control,49 and goal-directed behavior.49 Hare and colleagues50 found that participants who attempted to resist pleasurable foods also exhibited elevated DLPFC activation, which was linked to reduced activity in areas implicated in coding food reward, such as the ventromedial prefrontal cortex. Thus, participants with higher FA scores may respond to increased appetitive motivation for food by attempting to implement self-control strategies. It has also been suggested that DLPFC activation by drug cues relates to integration of information about internal state (craving, withdrawal), motivation, expectancy, and cues in the regulation and planning of drug-seeking behavior.8 Similarly, the caudate also appears to play a role in enhanced motivation. Elevated caudate activation is associated with expectation of a positive reward,51 exposure to cues with increased incentive value,52 and exposure to drug stimuli for substance-dependent participants.53 Thus, greater FA scores may be related to stronger motivations to seek out food in response to food-related cues.
Neural activation of regions that appear to play a role in the encoding of craving was also positively correlated with FA scores. For example, activation in the ACC and medial OFC is associated with craving in substance use disorders.54,55 The amygdala has also been commonly implicated in drug cue reactivity56 and drug craving.57 Further, activation in the caudate is associated with craving for palatable foods,58 as well as craving in response to drug cues in substance-dependent participants.53,59 Thus, FA scores may be associated with greater cue-triggered food cravings.
Finally, FA scores were associated with activation in regions that play a role in disinhibition and satiety. Interestingly, although FA was correlated positively with activation in the medial OFC during anticipatory food reward, FA scores were correlated negatively with activation in the lateral OFC during receipt of food. These findings are consistent with research showing very different patterns of response in these regions. Specifically, Small et al36 found that the medial and lateral caudal OFC showed opposite patterns of activity during chocolate consumption, prompting the suggestion that this pattern occurs as participants' desire to eat decreases and their behavior (eating) comes to be inconsistent with their desires. Thus, lateral OFC activity occurs when the desire to stop eating is suppressed. Similar dissociations between the medial and lateral OFC have also been found in substance dependence. Unlike the medial OFC, which is more closely related to subjective evaluation of reward,60 increased activation in the lateral OFC is associated with greater inhibitory control46,61 and a greater ability to suppress previously rewarded responses.62 Substance-dependent participants typically exhibit increased activation in the medial OFC in response to drug cues54,55 but also exhibit hypoactivation in the lateral OFC,46 suggesting less inhibitory control in response to reward cues. The reduced activation in the lateral OFC in individuals with high FA observed herein may be related to either less inhibitory control during intake of palatable food or a reduced satiety response during palatable food intake.
In sum, these findings support the theory that compulsive food consumption may be driven in part by an enhanced anticipation of the rewarding properties of food.13 Similarly, addicted individuals are more likely to be physiologically, psychologically, and behaviorally reactive to substance-related cues.63,64 This process may be due in part to incentive salience, which suggests that cues associated with the substance (in this case food) may begin triggering the release of dopamine and driving consumption.65,66 Brain regions associated with dopaminergic release also showed significantly greater activation during cue exposure in participants with high FA. The possibility that food-related cues may develop pathological properties is especially concerning in the current food environment where palatable foods are constantly available and heavily marketed.
In contrast to our initial hypotheses, there were limited differences in reward circuitry activation between participants with high FA and low FA during food intake. These findings provide little support for the notion that abnormal reward response to food intake drives FA. Instead, the high FA group exhibited patterns of neural activation associated with reduced inhibitory control. Previous studies have found that administration of a priming dose can trigger excessive consumption in participants with substance use problems67,68 and eating pathology.69-71 The current results, taken in concert with these previous findings, suggest that consumption of a palatable food may override desires to limit caloric food consumption in participants with high FA, resulting in disinhibited food consumption.
Interestingly, no significant correlation was found between YFAS scores and BMI. Thus, the current findings suggest that FA scores and related neural functioning can occur among individuals with a range of body weights. In the initial validation, the YFAS score was also not significantly related to BMI but was associated with binge eating, emotional eating, and problematic eating attitudes.26 Similarly, herein, the YFAS score was correlated with emotional eating and external eating. It is possible that some individuals experience compulsive eating behavior but engage in compensatory behaviors to maintain a lower weight. An alternative possibility is that lean participants who endorse FA are at risk for future weight gain. Given the young age of the sample, the probability of future weight gain may be especially likely. Either possibility suggests that examining FA in lean participants may be beneficial in identifying individuals at risk for weight gain or disordered eating and that the YFAS score may provide important information above and beyond current BMI.
It is important to consider the limitations of this study. First, potentially because of the exclusion of participants with eating disorders and Axis I disorders, few participants met the clinically significant distress or impairment criteria of the YFAS, which is required for an FA“diagnosis.” Thus, the current study should be considered a conservative test and future studies of the neural correlates of FA should include participants with more severe scores. Second, although we asked participants to refrain from eating 4 to 6 hours prior to their scan session, we did not measure hunger. Fasting and hunger are associated with similar patterns of neural response, such as increased activation in the medial OFC and amygdala.72,73 It is possible that participants with higher FA scores experienced more hunger. If this was the case, it may have contributed to some of the observed effects. It is also possible that increased hunger may interact with FA, because both addiction and hunger are associated with elevated drive.74 Future studies should examine the relation between FA, hunger, and reward circuitry response with food intake and anticipated intake. Third, the current study was conducted solely with female participants; thus, results should be generalized with caution to males. Fourth, this study is cross-sectional, which did not allow us to evaluate the time course of the development of FA and related neural correlates. A longitudinal design would allow for a greater understanding of the antecedents and consequences of FA. Fifth, regions implicated in the current study are also implicated in nonaddictive reward-related behavior; thus, future studies would benefit from collecting addiction-related measures during the scan, such as craving and loss of control. Finally, the sample size of the current study is relatively small; thus, there may have been limited power to detect other effects, such as individual differences in neural response to food intake.
The current findings have implications regarding future research directions. First, given that some types of eating behavior may be driven by food cues, it will be important to examine neural activation in response to food advertisements. In addition, to further explore the role of disinhibition in FAs, it will be useful to measure feelings of loss of control and ad libitum food consumption. Further, the use of functional MRI technology does not allow for the direct measurement of dopamine release or dopamine receptors. It will be important to examine induced dopamine release and D2 receptor availability in participants who report indicators of FA. Finally, although dopamine is implicated in both feeding and addictive behaviors, other neurotransmitters are also likely to play an important role (eg, opioid,γ-aminobutyric acid). Thus, future studies on the connection between FA and neural activation associated with these neurotransmitters will also be important.
Despite the aforementioned limitations, the current findings suggest that FA is associated with reward-related neural activation that is frequently implicated in substance dependence. To our knowledge, this is the first study to link indicators of addictive eating behavior with a specific pattern of neural activation. The current study also provides evidence that objectively measured biological differences are related to variations in YFAS scores, thus providing further support for the validity of the scale. Further, if certain foods are addictive, this may partially explain the difficulty people experience in achieving sustainable weight loss. If food cues take on enhanced motivational properties in a manner analogous to drug cues, efforts to change the current food environment may be critical to successful weight loss and prevention efforts. Ubiquitous food advertising and the availability of inexpensive palatable foods may make it extremely difficult to adhere to healthier food choices because the omnipresent food cues trigger the reward system. Finally, if palatable food consumption is accompanied by disinhibition, the current emphasis on personal responsibility as the anecdote to increasing obesity rates may have minimal effectiveness.
Correspondence: Ashley N. Gearhardt, MS, MPhil, 2 Hillhouse Ave, New Haven, CT 06511 (email@example.com).
Submitted for Publication: July 7, 2010; final revision received January 19, 2011; accepted January 29, 2011.
Published Online: April 4, 2011. doi:10.1001/archgenpsychiatry.2011.32
Author Contributions: Ms Gearhardt takes responsibility for the integrity of the data and the accuracy of the data analysis and states that all authors had full access to all the data in the study.
Financial Disclosure: None reported.
Funding/Support: This project was supported by Roadmap Supplement grant R1MH64560A.
Create a personal account or sign in to: